Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp242 | Anterior and Posterior Pituitary | ECE2019

Copeptin levels in SIADH – a marker of malignant disease?

Winzeler Bettina , Steinmetz Michelle , Refardt Julie , Cesana-Nigro Nicole , Popovic Milica , Fenske Wiebke , Christ-Crain Mirjam

Context: Hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a very common condition in hospitalized patients. It is crucial to establish the cause of SIADH especially in order to exclude or detect an underlying malignancy. As SIADH can be caused by paraneoplastically produced arginine vasopressin (AVP), we hypothesized that its stable surrogate marker copeptin may be used as a diagnostic tool.Methods: We analyzed ...

ea0063oc13.1 | Anterior and Posterior pituitary 2 | ECE2019

Arginine-stimulated copeptin measurements - a new test for diabetes insipidus

Winzeler Bettina , Nigro-Cesana Nicole , Refardt Julie , Vogt Deborah R , Imber Cornelia , Morin Benedict , Popovic Milica , Steinmetz Michelle , Sailer Clara , Szinnai Gabor , Chifu Irina , Fassnacht Martin , Christ-Crain Mirjam

Background: The differential diagnosis of diabetes insipidus is challenging. The most reliable diagnostic approach is hypertonic saline-stimulated copeptin measurements. However, as this test is based on the induction of hypernatremia, it is associated with adverse effects and needs close sodium monitoring. We hypothesized that arginine-stimulated copeptin measurements provide an alternative, simple and safe diagnostic test for diabetes insipidus.Methods...

ea0081p76 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Glucagon-like peptide-1 analogues: a new way to quit smoking? SKIP – a randomised controlled study

Lengsfeld Sophia , Burkard Thilo , Meienberg Andrea , Jeanloz Nica , Vukajlovic Tanja , Bologna Katja , Steinmetz Michelle , Sailer Clara , Coynel David , Vogt Deborah R , Hemkens Lars G. , Speich Benjamin , Kuhne Jill , Baur Fabienne , Lutz Linda , Bathelt Cemile , Zanchi Davide , Christ-Crain Mirjam , Winzeler Bettina

Background: Cigarette smoking is the leading preventable cause of premature death. Smoking cessation is one of the central goals in medicine, but despite dedicated programs, quit rates remain low due to barriers such as nicotine withdrawal syndrome or post-cessation weight gain. Glucagon-like peptide-1 (GLP-1) analogues reduce energy intake and body weight and seem to modulate addictive behavior. These GLP-1 properties are of major interest in the context of smoking cessation....